Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 18, 2006, to report its third-quarter financial results for the period ended September 30, 2006. The report primarily consists of a press release detailing these results, which is furnished as an exhibit. Investors should note that the information provided in this 8-K and its exhibit is not deemed "filed" for certain regulatory purposes, meaning it is not subject to the liabilities of Section 18 of the Exchange Act and will not be automatically incorporated into future SEC filings unless explicitly stated. While the specific financial figures are not detailed within the 8-K document itself but rather in the accompanying press release, the filing signals the company's regular reporting cadence. Investors would typically review the press release (Exhibit 99.1) for key performance indicators, revenue growth, profitability, and any forward-looking statements or significant business developments discussed by management for the third quarter of 2006.
Key Highlights
- 1Filing of an 8-K Current Report by Boston Scientific Corporation on October 18, 2006.
- 2The report pertains to the company's financial results for the third quarter ended September 30, 2006.
- 3The primary content of the 8-K is a press release announcing these quarterly results.
- 4Exhibit 99.1 contains the press release detailing the Q3 2006 financial performance.
- 5Information furnished in this report is not considered "filed" under Section 18 of the Securities Exchange Act of 1934.
- 6The filing serves as a standard disclosure of material information regarding the company's operational and financial condition.
- 7Investors are directed to the accompanying press release for specific financial details and commentary.